These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7032778)

  • 41. [Pathophysiology of atherosclerosis. II. Etiopathogenic mechanisms and risk factors].
    Reiner Z; Tedeschi-Reiner E
    Lijec Vjesn; 1990; 112(5-6):175-82. PubMed ID: 2233116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atherosclerosis--reversal with therapy.
    Blankenhorn DH; Hodis HN
    West J Med; 1993 Aug; 159(2):172-9. PubMed ID: 8212682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].
    Drouet L; Mazoyer E; Bal dit Sollier C; Hainaud P; Ripoll L
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():41-51. PubMed ID: 9833079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of the endothelium and blood platelets in the pathogenesis of atherosclerosis.
    Constantinides P
    Triangle; 1976; 15(2-3):53-61. PubMed ID: 788258
    [No Abstract]   [Full Text] [Related]  

  • 46. [Biochemistry of atherogenesis: effects of prostaglandins (author's transl)].
    Dousset JC
    Pathol Biol (Paris); 1981 Jan; 29(1):53-61. PubMed ID: 7010278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.
    Kalinina N; Agrotis A; Antropova Y; DiVitto G; Kanellakis P; Kostolias G; Ilyinskaya O; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2320-5. PubMed ID: 15374849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Functional changes of the endothelium and atherosclerotic process].
    Montrucchio G; Emanuelli G; Venco A; Camussi G
    Ann Ital Med Int; 1995; 10(1):31-40. PubMed ID: 7727204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.
    Siegel-Axel D; Daub K; Seizer P; Lindemann S; Gawaz M
    Cardiovasc Res; 2008 Apr; 78(1):8-17. PubMed ID: 18218686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atherosclerosis.
    Ross R
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S714-9. PubMed ID: 6083415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components.
    Ross R
    Arteriosclerosis; 1981; 1(5):293-311. PubMed ID: 6287982
    [No Abstract]   [Full Text] [Related]  

  • 52. Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.
    Newby AC; Zaltsman AB
    Cardiovasc Res; 1999 Feb; 41(2):345-60. PubMed ID: 10341834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelets and atherosclerosis.
    Saunders RN
    Prog Drug Res; 1985; 29():49-66. PubMed ID: 3911264
    [No Abstract]   [Full Text] [Related]  

  • 54. Cell biology of atherosclerosis.
    Ross R
    Annu Rev Physiol; 1995; 57():791-804. PubMed ID: 7778883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
    Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
    Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N; Fukuda N; Tremblay J; Hamet P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelets, platelet-derived growth factor, growth control, and their interactions with the vascular wall.
    Ross R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 3():S186-90. PubMed ID: 2409393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Possible significance of blood platelets in the early stage or arteriosclerosis].
    Tschopp TB; Baumgartner HR
    Med Welt; 1977 Oct; 28(41):1656-7. PubMed ID: 927126
    [No Abstract]   [Full Text] [Related]  

  • 59. Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces.
    Lüscher TF
    Blood Press Suppl; 1994; 1():18-22. PubMed ID: 8205293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions.
    Akopov S; Sercombe R; Seylaz J
    Cerebrovasc Brain Metab Rev; 1996; 8(1):11-94. PubMed ID: 9052980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.